Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -277,000 | -185,000 | -575,000 | -446,444 | -266,000 |
| Depreciation Amortization | 15,000 | 7,000 | 31,000 | 22,731 | 15,000 |
| Accounts receivable | -43,000 | 19,000 | -31,000 | 2,834 | -3,000 |
| Other Working Capital | -80,000 | -51,000 | -23,000 | -23,588 | -79,000 |
| Other Operating Activity | 91,000 | 13,000 | 132,000 | 78,296 | 58,000 |
| Operating Cash Flow | $-294,000 | $-197,000 | $-466,000 | $-366,171 | $-275,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | N/A | 258,000 | 329,582 | 210,000 |
| PPE Investments | -2,000 | -1,000 | -6,000 | -5,062 | -4,000 |
| Purchase Of Investment | N/A | -131,000 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 88,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -5,000 | -5,000 | -15,000 | -15,000 | -15,000 |
| Other Investing Activity | -8,000 | -5,000 | -16,000 | -16,273 | -15,000 |
| Investing Cash Flow | $-5,000 | $-49,000 | $236,000 | $308,247 | $191,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,000 | N/A | 86,000 | 83,808 | 84,000 |
| Other Financing Activity | 0 | 0 | 392,000 | 0 | 0 |
| Financing Cash Flow | $3,000 | $N/A | $478,000 | $83,808 | $84,000 |
| Exchange Rate Effect | N/A | -1,000 | 4,000 | 4,656 | 5,000 |
| Beginning Cash Position | 436,000 | 436,000 | 184,000 | 184,159 | 184,000 |
| End Cash Position | 140,000 | 189,000 | 436,000 | 214,699 | 189,000 |
| Net Cash Flow | $-296,000 | $-247,000 | $252,000 | $30,540 | $5,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -294,000 | -197,000 | -466,000 | -366,171 | -275,000 |
| Capital Expenditure | -2,000 | -1,000 | -6,000 | -5,062 | -4,000 |
| Free Cash Flow | -296,000 | -198,000 | -472,000 | -371,233 | -279,000 |